Galderma Investigational Site 5437

Kiel, Schleswig-Holst 24105

0 studies enrolling now · 1 studies all time

What they study most

Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed